Medical - Care Facilities
Compare Stocks
5 / 10Stock Comparison
PIII vs CNC vs MOH vs UNH vs CVS
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Plans
Medical - Healthcare Plans
Medical - Healthcare Plans
Medical - Healthcare Plans
PIII vs CNC vs MOH vs UNH vs CVS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Care Facilities | Medical - Healthcare Plans | Medical - Healthcare Plans | Medical - Healthcare Plans | Medical - Healthcare Plans |
| Market Cap | $11M | $27.13B | $9.99B | $335.60B | $111.40B |
| Revenue (TTM) | $1.44B | $198.10B | $45.08B | $449.71B | $407.90B |
| Net Income (TTM) | $-131M | $-6.44B | $188M | $12.04B | $2.93B |
| Gross Margin | 48.2% | 14.9% | 9.6% | 18.8% | 13.9% |
| Operating Margin | -17.6% | -3.7% | 1.2% | 4.2% | 1.5% |
| Forward P/E | — | 16.3x | 37.2x | 20.2x | 12.2x |
| Total Debt | $166M | $18.78B | $3.95B | $78.39B | $93.59B |
| Cash & Equiv. | $39M | $17.89B | $4.25B | $24.36B | $8.51B |
PIII vs CNC vs MOH vs UNH vs CVS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 21 | May 26 | Return |
|---|---|---|---|
| P3 Health Partners … (PIII) | 100 | 0.7 | -99.3% |
| Centene Corporation (CNC) | 100 | 89.0 | -11.0% |
| Molina Healthcare, … (MOH) | 100 | 75.2 | -24.8% |
| UnitedHealth Group … (UNH) | 100 | 92.7 | -7.3% |
| CVS Health Corporat… (CVS) | 100 | 114.3 | +14.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: PIII vs CNC vs MOH vs UNH vs CVS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
PIII is the clearest fit if your priority is growth exposure.
- Rev growth 18.5%, EPS growth -77.6%, 3Y rev CAGR 33.0%
CNC is the #2 pick in this set and the best alternative if growth and value is your priority.
- 19.4% revenue growth vs CVS's 7.8%
- Lower P/E (16.3x vs 20.2x)
Among these 5 stocks, MOH doesn't own a clear edge in any measured category.
UNH carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 220.6% 10Y total return vs MOH's 306.6%
- 2.7% margin vs PIII's -9.1%
- 2.4% yield, 25-year raise streak, vs CVS's 3.1%, (3 stocks pay no dividend)
- 3.9% ROA vs PIII's -19.2%, ROIC 9.2% vs -60.2%
CVS ranks third and is worth considering specifically for income & stability and sleep-well-at-night.
- Dividend streak 0 yrs, beta 0.05, yield 3.1%
- Lower volatility, beta 0.05, current ratio 0.84x
- Beta 0.05, yield 3.1%, current ratio 0.84x
- Beta 0.05 vs UNH's 0.59
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.4% revenue growth vs CVS's 7.8% | |
| Value | Lower P/E (16.3x vs 20.2x) | |
| Quality / Margins | 2.7% margin vs PIII's -9.1% | |
| Stability / Safety | Beta 0.05 vs UNH's 0.59 | |
| Dividends | 2.4% yield, 25-year raise streak, vs CVS's 3.1%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +34.7% vs PIII's -58.5% | |
| Efficiency (ROA) | 3.9% ROA vs PIII's -19.2%, ROIC 9.2% vs -60.2% |
PIII vs CNC vs MOH vs UNH vs CVS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
PIII vs CNC vs MOH vs UNH vs CVS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
UNH leads in 2 of 6 categories
CVS leads 1 • PIII leads 0 • CNC leads 0 • MOH leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
UNH leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UNH is the larger business by revenue, generating $449.7B annually — 311.2x PIII's $1.4B. UNH is the more profitable business, keeping 2.7% of every revenue dollar as net income compared to PIII's -9.1%. On growth, CNC holds the edge at +7.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.4B | $198.1B | $45.1B | $449.7B | $407.9B |
| EBITDAEarnings before interest/tax | -$171M | -$5.9B | $710M | $23.2B | $10.5B |
| Net IncomeAfter-tax profit | -$131M | -$6.4B | $188M | $12.0B | $2.9B |
| Free Cash FlowCash after capex | -$123M | $6.3B | $251M | $19.7B | $7.4B |
| Gross MarginGross profit ÷ Revenue | +48.2% | +14.9% | +9.6% | +18.8% | +13.9% |
| Operating MarginEBIT ÷ Revenue | -17.6% | -3.7% | +1.2% | +4.2% | +1.5% |
| Net MarginNet income ÷ Revenue | -9.1% | -3.3% | +0.4% | +2.7% | +0.7% |
| FCF MarginFCF ÷ Revenue | -8.5% | +3.2% | +0.6% | +4.4% | +1.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -4.7% | +7.1% | -3.1% | +2.0% | +6.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +38.4% | +18.3% | -95.0% | +0.7% | +63.1% |
Valuation Metrics
Evenly matched — PIII and CNC each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 21.5x trailing earnings, MOH trades at a 66% valuation discount to CVS's 62.8x P/E. On an enterprise value basis, MOH's 9.9x EV/EBITDA is more attractive than UNH's 16.7x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $11M | $27.1B | $10.0B | $335.6B | $111.4B |
| Enterprise ValueMkt cap + debt − cash | $138M | $28.0B | $9.7B | $389.6B | $196.5B |
| Trailing P/EPrice ÷ TTM EPS | -0.07x | -4.03x | 21.50x | 27.95x | 62.81x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 16.29x | 37.20x | 20.19x | 12.19x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | 9.93x | 16.70x | 13.11x |
| Price / SalesMarket cap ÷ Revenue | 0.01x | 0.14x | 0.22x | 0.75x | 0.28x |
| Price / BookPrice ÷ Book value/share | 0.07x | 1.35x | 2.39x | 3.31x | 1.47x |
| Price / FCFMarket cap ÷ FCF | — | 6.28x | — | 20.88x | 14.27x |
Profitability & Efficiency
UNH leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
UNH delivers a 11.5% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-7 for PIII. UNH carries lower financial leverage with a 0.77x debt-to-equity ratio, signaling a more conservative balance sheet compared to CVS's 1.24x. On the Piotroski fundamental quality scale (0–9), CNC scores 6/9 vs PIII's 2/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -6.9% | -28.6% | +4.4% | +11.5% | +3.9% |
| ROA (TTM)Return on assets | -19.2% | -7.9% | +1.2% | +3.9% | +1.1% |
| ROICReturn on invested capital | -60.2% | -21.6% | +17.4% | +9.2% | +5.0% |
| ROCEReturn on capital employed | -75.6% | -14.6% | +9.8% | +9.7% | +6.1% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 6 | 4 | 6 | 5 |
| Debt / EquityFinancial leverage | 1.11x | 0.94x | 0.97x | 0.77x | 1.24x |
| Net DebtTotal debt minus cash | $127M | $889M | -$298M | $54.0B | $85.1B |
| Cash & Equiv.Liquid assets | $39M | $17.9B | $4.2B | $24.4B | $8.5B |
| Total DebtShort + long-term debt | $166M | $18.8B | $4.0B | $78.4B | $93.6B |
| Interest CoverageEBIT ÷ Interest expense | -5.02x | -9.03x | 2.12x | 4.71x | 2.11x |
Total Returns (Dividends Reinvested)
CVS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CVS five years ago would be worth $11,700 today (with dividends reinvested), compared to $74 for PIII. Over the past 12 months, CVS leads with a +34.7% total return vs PIII's -58.5%. The 3-year compound annual growth rate (CAGR) favors CVS at 11.0% vs PIII's -66.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +2.3% | +31.5% | +7.5% | +10.6% | +10.6% |
| 1-Year ReturnPast 12 months | -58.5% | -12.7% | -41.3% | -3.2% | +34.7% |
| 3-Year ReturnCumulative with dividends | -96.3% | -19.5% | -35.0% | -19.9% | +36.6% |
| 5-Year ReturnCumulative with dividends | -99.3% | -22.0% | -28.4% | -2.6% | +17.0% |
| 10-Year ReturnCumulative with dividends | -99.3% | +81.2% | +306.6% | +220.6% | +3.5% |
| CAGR (3Y)Annualised 3-year return | -66.6% | -7.0% | -13.4% | -7.1% | +11.0% |
Risk & Volatility
Evenly matched — MOH and CVS each lead in 1 of 2 comparable metrics.
Risk & Volatility
MOH is the less volatile stock with a -0.04 beta — it tends to amplify market swings less than UNH's 0.59 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CVS currently trades 98.5% from its 52-week high vs PIII's 31.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.14x | 0.39x | -0.04x | 0.59x | 0.05x |
| 52-Week HighHighest price in past year | $11.30 | $64.15 | $333.00 | $395.52 | $88.63 |
| 52-Week LowLowest price in past year | $1.52 | $25.08 | $121.06 | $234.60 | $58.35 |
| % of 52W HighCurrent price vs 52-week peak | +31.7% | +85.7% | +57.6% | +93.5% | +98.5% |
| RSI (14)Momentum oscillator 0–100 | 53.9 | 83.5 | 77.1 | 75.9 | 69.3 |
| Avg Volume (50D)Average daily shares traded | 62K | 5.8M | 1.4M | 7.9M | 7.4M |
Analyst Outlook
Evenly matched — UNH and CVS each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PIII as "Buy", CNC as "Buy", MOH as "Buy", UNH as "Buy", CVS as "Buy". Consensus price targets imply 249.2% upside for PIII (target: $13) vs -13.4% for MOH (target: $166). For income investors, CVS offers the higher dividend yield at 3.06% vs UNH's 2.35%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $12.50 | $51.00 | $166.09 | $385.43 | $95.20 |
| # AnalystsCovering analysts | 4 | 43 | 38 | 52 | 41 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +2.4% | +3.1% |
| Dividend StreakConsecutive years of raises | — | 1 | — | 25 | 0 |
| Dividend / ShareAnnual DPS | — | — | — | $8.70 | $2.67 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.8% | +10.0% | +1.7% | 0.0% |
UNH leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CVS leads in 1 (Total Returns). 3 tied.
PIII vs CNC vs MOH vs UNH vs CVS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is PIII or CNC or MOH or UNH or CVS a better buy right now?
For growth investors, Centene Corporation (CNC) is the stronger pick with 19.
4% revenue growth year-over-year, versus 7. 8% for CVS Health Corporation (CVS). Molina Healthcare, Inc. (MOH) offers the better valuation at 21. 5x trailing P/E (37. 2x forward), making it the more compelling value choice. Analysts rate P3 Health Partners Inc. (PIII) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — PIII or CNC or MOH or UNH or CVS?
On trailing P/E, Molina Healthcare, Inc.
(MOH) is the cheapest at 21. 5x versus CVS Health Corporation at 62. 8x. On forward P/E, CVS Health Corporation is actually cheaper at 12. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — PIII or CNC or MOH or UNH or CVS?
Over the past 5 years, CVS Health Corporation (CVS) delivered a total return of +17.
0%, compared to -99. 3% for P3 Health Partners Inc. (PIII). Over 10 years, the gap is even starker: MOH returned +306. 6% versus PIII's -99. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — PIII or CNC or MOH or UNH or CVS?
By beta (market sensitivity over 5 years), Molina Healthcare, Inc.
(MOH) is the lower-risk stock at -0. 04β versus UnitedHealth Group Incorporated's 0. 59β — meaning UNH is approximately -1702% more volatile than MOH relative to the S&P 500. On balance sheet safety, UnitedHealth Group Incorporated (UNH) carries a lower debt/equity ratio of 77% versus 124% for CVS Health Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — PIII or CNC or MOH or UNH or CVS?
By revenue growth (latest reported year), Centene Corporation (CNC) is pulling ahead at 19.
4% versus 7. 8% for CVS Health Corporation (CVS). On earnings-per-share growth, the picture is similar: UnitedHealth Group Incorporated grew EPS -14. 7% year-over-year, compared to -315. 8% for Centene Corporation. Over a 3-year CAGR, PIII leads at 33. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — PIII or CNC or MOH or UNH or CVS?
UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.
7% net margin versus -9. 1% for P3 Health Partners Inc. — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus -21. 4% for PIII. At the gross margin level — before operating expenses — PIII leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is PIII or CNC or MOH or UNH or CVS more undervalued right now?
On forward earnings alone, CVS Health Corporation (CVS) trades at 12.
2x forward P/E versus 37. 2x for Molina Healthcare, Inc. — 25. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PIII: 249. 2% to $12. 50.
08Which pays a better dividend — PIII or CNC or MOH or UNH or CVS?
In this comparison, CVS (3.
1% yield), UNH (2. 4% yield) pay a dividend. PIII, CNC, MOH do not pay a meaningful dividend and should not be held primarily for income.
09Is PIII or CNC or MOH or UNH or CVS better for a retirement portfolio?
For long-horizon retirement investors, CVS Health Corporation (CVS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
05), 3. 1% yield). Both have compounded well over 10 years (CVS: +3. 5%, CNC: +81. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between PIII and CNC and MOH and UNH and CVS?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: PIII is a small-cap high-growth stock; CNC is a mid-cap high-growth stock; MOH is a small-cap quality compounder stock; UNH is a large-cap quality compounder stock; CVS is a mid-cap income-oriented stock. UNH, CVS pay a dividend while PIII, CNC, MOH do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.